New growth hormone shot for children with growth delay
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This study tests a new growth hormone injection (GB08) for children who are not growing well because of a condition called growth hormone deficiency. It aims to see if the medicine is safe and helps them grow taller.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child must be diagnosed with growth hormone deficiency by a doctor.
- The child must be a girl between 3 and 10 years old, or a boy between 3 and 11 years old, and not yet started puberty.
- The child must be significantly shorter than other children their age and sex, growing less than 2 inches per year.
- Growth hormone stimulation tests (two specific blood tests) must show very low levels.
- The child must not have received any previous growth hormone treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new growth hormone medicine (GB06) for children whose bodies don't make enough growth hormone naturally. The study will see if this treatment helps children grow taller over time.
This study looks at whether consistently taking growth hormone (Norditropin) helps children reach a height goal by “near final height.” It focuses on children who are short due to growth hormone deficiency or born small for gestational age.
This trial tests a new medicine called LUM-201 for children who haven't grown enough because their bodies don't make enough growth hormone. It aims to help kids who haven't been treated before and are still at an early stage of puberty.
This study tests a new growth hormone treatment called GenSci134 for children who have not yet gone through puberty and are not growing because their bodies do not make enough growth hormone. The goal is to see if the medicine helps them grow taller.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
Hear when a new Growth Hormone Deficiency in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.